Cross-reactivity between hepatitis C virus and influenza a virus determinant-specific cytotoxic T cells

Journal of Virology

Volumn 75, Issue 23, 2001, Pages 11392-11400

  Wedemeyer, H ^a   Mizukoshi, E ^a   Davis, A R ^a   Bennink, J R ^a   Rehermann, B ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE; SIALIDASE; VIRUS PROTEIN; VIRUS VACCINE;

ACUTE HEPATITIS; AMINO ACID SEQUENCE; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CELL SPECIFICITY; CELLULAR IMMUNITY; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; EXPOSURE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; INFLUENZA VIRUS A; LIVER INJURY; MEMORY CELL; MOUSE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; SEQUENCE HOMOLOGY; SPLEEN CELL; TRANSGENIC MOUSE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPACIVIRUS; HEPATITIS C, CHRONIC; HLA-A2 ANTIGEN; HUMANS; IMMUNODOMINANT EPITOPES; INFLUENZA A VIRUS; MICE; MICE, TRANSGENIC; VIRAL NONSTRUCTURAL PROTEINS;

EID: 0035163814     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.23.11392-11400.2001     Document Type: Article

References (50)

1. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
2. Influenza basic polymerase 2 peptides are recognized by influenza nucleoprotein-specific cytotoxic T lymphocytes
3. Kinetic and structural analyses of hepatitis C virus polyprotein processing
4. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms
5. Comparative nucleotide sequences at the 3′ end of the neuraminidase gene from eleven influenza type A viruses
6. The class I restricted cytotoxic T lymphocyte response to predetermined epitopes in the hepatitis B and C viruses
7. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif
8. Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus
9. Differential CD4 and CD8 T-cell responsiveness in hepatitis C virus infection
10. Modification of cysteine residues in vitro and in vivo affects the immunogenicity and antigenicity of major histocompatibility complex class I-restricted viral determinants
11. + T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection
12. Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood
13. Virus-specific CD8+ T cells in primary and secondary influenza pneumonia
14. Association of hepatitis C virus-specific CDS+ T cells with viral clearance in acute hepatitis C
15. Systemic T cell expansion during localized viral infection
16. Selective expansion of cross-reactive CD8(+) memory T cells by viral variants
17. Activation of autoreactive T cells by peptides from human pathogens
18. Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease
19. Virus-specific CDS+ T-cell memory determined by clonal burst size
20. Polyclonality and multispecificity of the CTL response to a single viral epitope
21. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis
22. Formulation and application of a numerical scoring system for assessing histological activity in symptomatic chronic active hepatitis
23. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release
24. Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons
25. Recognition of disparate HA and NS1 peptides by an H-2Kd-restricted, influenza specific CTL clone
26. 10-Year follow-up after interferon-alpha therapy for chronic hepatitis C
27. Cytotoxic T-cell memory without antigen
28. CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained
29. Analysis of successful immune responses in persons infected with hepatitis C virus
30. Differential contact of disparate class 1/peptide complexes as the basis for epitope cross-recognition by a single T cell receptor
31. The long-term maintenance of cytotoxic T cell memory does not require persistence of antigen
32. Importance of MHC class 1 alpha2 and alpha3 domains in the recognition of self and non-self MHC molecules
33. Resting memory CD8+ T cells are hyperreactive to antigenic challenge in vitro
34. Differential cytotoxic T lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients
35. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response, disease activity and viral load in patients with chronic hepatitis C virus infection
36. Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors
37. Attrition of T cell memory: Selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses
38. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses
39. Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations
40. Specificity of peptide binding by the HLA-A2.1 molecule
41. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1
42. Nucleotide sequences of cDNA clones encoding wheat germ agglutinin isolectins A and D
43. Lymphocyte life-span and memory
44. Cellular immune responses persist, humoral responses decrease two decades after recovery from a single source outbreak of hepatitis C
45. Turnover of naive- and memory-phenotype T cells
46. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex
47. Influenza virus lung infection protects from respiratory syncytial virus-induced immunopathology
48. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant
49. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: Frequency, specificity and T-cell receptor usage of pp65-specific CTL
50. 2.2 A resolution structure analysis of two refined N-acetylneuraminyl-lactose-wheat germ agglutinin isolectin complexes